Abstract:Hepatocellular carcinoma (HCC) is the primary liver cancer that occurs the most frequently. The risk of developing HCC is highest in those with chronic liver diseases, such as cirrhosis brought on by hepatitis B or C infection and the most common type of liver cancer. Knowledge-based interpretations are essential for understanding the HCC microarray dataset due to its nature, which includes high dimensions and hidden biological information in genes. When analyzing gene expression data with many genes and few samples, the main problem is to separate disease-related information from a vast quantity of redundant gene expression data and their noise. Clinicians are interested in identifying the specific genes responsible for HCC in individual patients. These responsible genes may differ between patients, leading to variability in gene selection. Moreover, ML approaches, such as classification algorithms, are similar to black boxes, and it is important to interpret the ML model outcomes. In this paper, we use a reliable pipeline to determine important genes for discovering HCC from microarray analysis. We eliminate redundant and unnecessary genes through gene selection using principal component analysis (PCA). Moreover, we detect responsible genes with the random forest algorithm through variable importance ranking calculated from the Gini index. Classification algorithms, such as random forest (RF), naïve Bayes classifier (NBC), logistic regression, and k-nearest neighbor (kNN) are used to classify HCC from responsible genes. However, classification algorithms produce outcomes based on selected genes for a large group of patients rather than for specific patients. Thus, we apply the local interpretable model-agnostic explanations (LIME) method to uncover the AI-generated forecasts as well as recommendations for patient-specific responsible genes. Moreover, we show our pathway analysis and a dendrogram of the pathway through hierarchical clustering of the responsible genes. There are 16 responsible genes found using the Gini index, and CCT3 and KPNA2 show the highest mean decrease in Gini values. Among four classification algorithms, random forest showed 96.53% accuracy with a precision of 97.30%. Five-fold cross-validation was used in order to collect multiple estimates and assess the variability for the RF model with a mean ROC of 0.95±0.2. LIME outcomes were interpreted for two random patients with positive and negative effects. Therefore, we identified 16 responsible genes that can be used to improve HCC diagnosis or treatment. The proposed framework using machine-learning-classification algorithms with the LIME method can be applied to find responsible genes to diagnose and treat HCC patients.

An Integrative Machine Learning Approach in Detecting Gene Networks Predicting Liver Cancer Incidence and Survival

WGCNA combined with machine learning to find potential biomarkers of liver cancer

Screening of Hub Genes in Hepatocellular Carcinoma Based on Network Analysis and Machine Learning

Machine learning approach to predict blood-secretory proteins and potential biomarkers for liver cancer using omics data

An integrated bioinformatics approach to early diagnosis, prognosis and therapeutics of non-small-cell lung cancer

Identification of potential crucial genes associated with the pathogenesis and prognosis of liver hepatocellular carcinoma

Identification of potential feature genes in non-alcoholic fatty liver disease using bioinformatics analysis and machine learning strategies

Machine-Learning Classification Models to Predict Liver Cancer with Explainable AI to Discover Associated Genes

Explainable machine learning model identified potential biomarkers in liver cancer survival prediction

Optimizing Prognostic Predictions in Liver Cancer with Machine Learning and Survival Analysis

Establishment of diagnostic model and identification of diagnostic markers between liver cancer and cirrhosis based on multi-chip and machine learning

Machine Learning Screens Potential Drugs Targeting a Prognostic Gene Signature Associated With Proliferation in Hepatocellular Carcinoma

Identifying Liver Metastasis-Related Genes Through a Coexpression Network to Construct a 5-Gene Model for Predicting Pancreatic Ductal Adenocarcinoma Patient Prognosis

A universal co-expression gene network and prognostic model for hepatic-biliary-pancreatic cancers identified by integrative analyses

Construction of a Liver Cancer Prognostic Model Based on Interferon-Gamma-Related Genes for Revealing the Immune Landscape

Integrating bioinformatics and machine learning methods to analyze diagnostic biomarkers for HBV-induced hepatocellular carcinoma

Early warning and diagnosis of liver cancer based on dynamic network biomarker and deep learning

From Big Data to Diagnosis and Prognosis: Gene Expression Signatures in Liver Hepatocellular Carcinoma

Machine learning-based proteogenomic data modeling identifies circulating plasma biomarkers for early detection of lung cancer

Construction of immune-related molecular diagnostic and predictive models of hepatocellular carcinoma based on machine learning

A refined therapeutic plan based on the machine-learning prognostic model of liver hepatocellular carcinoma